Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | DOI: 10.5507/bp.2024.010
Effect of treatment with carteolol and latanoprost in newly diagnosed primary open-angle glaucoma on peripapillary vessel density
- CTU in Prague, Faculty of Biomedical Engineering, 272 01 Kladno 2, Czech Republic
Background and Aim. In a previous follow-up of glaucoma patients taking carteolol or latanoprost, we found a greater progression of visual field changes with the prostaglandin than the betablocker. In the present study we compared the impact of carteolol and latanoprost on peripapillary vessel density in newly diagnosed primary open-angle glaucoma (POAG) patients.
Methods: The study consisted of two groups of POAG patients. There were 46 patient eyes treated with carteolol (Carteol LP 2%) in the first group and 52 eyes treated with latanoprost (Xalatan 0.005%) in the second. Intraocular pressure (IOP), vessel density (VD) and visual field were assessed in all patients. VD was measured peripapillary by optical coherence tomography angiography (OCTA) with the Avanti RTVue XR in eight segments: Inferior Temporal - IT (1); Temporal Inferior -TI (2); Temporal Superior - TS (3); Superior Temporal - ST (4); Superior Nasal - SN (5); Nasal Superior - NS (6); Nasal Inferior - NI (7) and Inferior Nasal - IN (8). The measurements were compared before and after three months of treatment. The visual field was examined with a fast threshold glaucoma program using a Medmont M 700 instrument from Medmont International Pty Ltd. and only when a diagnosis of POAG was done. The overall defect (OD) was assessed.
Results: Before treatment, there was no difference between groups in either OD or VD. After treatment, there was a decrease in IOP in both groups. In the carteolol-treated group, the mean decrease was 5.8 mmHg and in the latanoprost-treated eyes, the mean decrease was 7 mmHg. The difference was not statistically significant (P=0.133). After treatment with carteolol, there was a statistically significant increase in VD in segments 4, 5 and 6. After latanoprost treatment, VD was statistically significantly improved only in segment 5. A greater increase in VD values was found in eyes treated with carteolol than in eyes treated with latanoprost.
Conclusion: Carteolol had a better effect on vessel density than latanoprost.
Keywords: primary open-angle glaucoma, peripapillary vessel density, treatment with carteolol and latanoprost.
Received: December 5, 2023; Accepted: February 26, 2024; Prepublished online: March 21, 2024
References
- Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005;24:39-73.
Go to original source...
Go to PubMed...
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. Jama 2014;311:1901-11.
Go to original source...
Go to PubMed...
- Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53.
Go to original source...
Go to PubMed...
- Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
Go to original source...
Go to PubMed...
- Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs 2000;59:411-34.
Go to original source...
Go to PubMed...
- Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm 2005;62:691-9.
Go to original source...
Go to PubMed...
- Kashiwagi K. Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community. Open Ophthalmol J 2010;28:7-11.
Go to original source...
Go to PubMed...
- Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K. Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis. Ophthalmology 2016;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005
Go to original source...
Go to PubMed...
- Li F, Huang W, Zhang X. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis. Acta Ophthalmologica 2018;96(3):e277-e284. doi: 10.1111/aos.13568
Go to original source...
Go to PubMed...
- Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, Li T, Mansberger SL; American Academy of Ophthalmology Preferred Practice Pattern Glaucoma Panel. Primary Open-Angle Glaucoma Preferred Practice Pattern®. Ophthalmology. 2021;128(1):P71-P150. doi: 10.1016/j.ophtha.2020.10.022
Go to original source...
Go to PubMed...
- Matsuo M, Kuse Y, Takahashi K, Kuwahara K, Tanito M, Kaidzu S, Shimazawa M, Hara H, Ohira A. Carteolol hydrochloride reduces visible light-induced retinal damage in vivo and BSO/glutamate-induced oxidative stress in vitro. J Pharmacol Sci 2019;139(2):84-90. doi: 10.1016/j.jphs.2018.11.010
Go to original source...
Go to PubMed...
- Frishman WH, Fuksbrumer MS, Tannenbaum. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension. J Clin Pharmacol 1994;34:795-803.
Go to original source...
Go to PubMed...
- Perry CM McGavin JK, Culy CR, Ibbotson T. Latanoprost: an update of its use in glaucoma and ocular hypertension. Drugs Aging 2003;20:597-630.
Go to original source...
Go to PubMed...
- Kral J, Lestak J, Nutterova E. OCT angiography, RNFL and visual field at different values of intraocular pressure. Biomed Rep 2022;16:36. doi: 10.3892/br.2022.1519
Go to original source...
Go to PubMed...
- Lestak J, Fus M, Kral J. Axons of retinal ganglion cells on the optic nerve target at different values of intraocular pressure. Clin Ophthalmol 2022;16:3673-9.
Go to original source...
Go to PubMed...
- Lešták J, Fůs M, Král J. Axons of retinal ganglion cells on the optic nerve disc following vessel density correction at diferent IOP values. Exp Ther Med 2023;25(6):261. doi: 10.3892/etm.2023.11960
Go to original source...
Go to PubMed...
- Nutterova E, Fus M, Bartosova L, Klimesova I, Lestak J. Comparison of the Effect on Vessel Density and RNFL between Carteolol and Latanoprost. J Clin Med 2022;11(14):4159. doi: 10.3390/jcm11144159
Go to original source...
Go to PubMed...
- Choi J, Kook MS. Systemic and ocular hemodynamic risk factors in glaucoma. Biomed Res Int 2015;2015:141905. doi: 10.1155/2015/141905
Go to original source...
Go to PubMed...
- Siesky B, Harris A, Vercellin ACV, Guidoboni G, Tsai JC. Ocular blood flow as it relates to race and disease on glaucoma. Adv Ophthalmol Optom 2021;6:245-62. doi: 10.1016/j.yaoo.2021.04.016
Go to original source...
Go to PubMed...
- Lestak J, Fus M, Rybar M, Benda A. OCTA and doppler ultrasound in primary open-angle glaucoma and normal-tension glaucoma. Life 2023;13(3):610. doi: 10.3390/life13030610
Go to original source...
Go to PubMed...
- Nakazawa T. Ocular blood flow and influencing factors for glaucoma. Asia Pac J Ophthalmol (Phila) 2016;5:38-44. doi: 10.1097/APO.0000000000000183
Go to original source...
Go to PubMed...
- Lešták J, Fůs M, Benda A, Bartošová L, Marešová K. OCT Angiography and Doppler Ultrasound in Hypertensive Glaucoma. Cesk Slov Oftalmol 2021;77:130-3. doi: 10.31348/2021/15
Go to original source...
Go to PubMed...
- Garhöfer G, Bata AM, Popa-Cherecheanu A, Hommer A, Vass C, Resch H, Schmidl D, Werkmeister RM, Schmetterer L. Retinal Oxygen Extraction in Patients with Primary Open-Angle Glaucoma. Int J Mol Sci 2022;23(17):10152. doi: 10.3390/ijms231710152
Go to original source...
Go to PubMed...
- Marquis RE, Whitson JT. Management of glaucoma: focus on pharmacological therapy. Drugs Aging 2005;22(1):1-21.
Go to original source...
Go to PubMed...
- Díaz F , Villena A, Vidal L, Moreno M, García-Campos J, Pérez de Vargas I. Experimental model of ocular hypertension in the rat: study of the optic nerve capillaries and action of hypotensive drugs. Invest Ophthalmol Vis Sci 2010;51:946-51.
Go to original source...
Go to PubMed...
- Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 1991;32:484-91.
- Morgan JE, Uchida H, Caprioli J. Retinal ganglion cell death in experimental glaucoma. Br J Ophthalmol 2000;84:303-10.
Go to original source...
Go to PubMed...
- Naskar R, Wissing M, Thanos S. Detection of Early Neuron Degeneration and Accompanying Microglial Responses in the Retina of a Rat Model of Glaucoma. Invest Ophthalmol Vis Sci 2002;43:2962-8.
- Shou T, Liu J, Wang W, Zhou Y, Zhao K. Differential dendritic shrinkage of alpha and beta retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci 2003;44:3005-10.
Go to original source...
Go to PubMed...
- Mukai R, Park DH, Okunuki Y, Hasegawa E, Klokman G, Kim CB, Krishnan A, Gregory-Ksander M, Husain D, Miller JW, Connor KM. Mouse model of ocular hypertension with retinal ganglion cell degeneration. PLoS One 2019;14(1):e0208713. doi: 10.1371/journal.pone.0208713
Go to original source...
Go to PubMed...
- Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988;95:357-63.
Go to original source...
Go to PubMed...
- Soto I, Oglesby E, Buckingham BP, Son JL, Roberson ED, Steele MR, Inman DM, Vetter ML, Horner PJ, Marsh-Armstrong N. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 2008;28(2):548-61. doi: 10.1523/JNEUROSCI.3714-07.2008
Go to original source...
Go to PubMed...
- Vorwerk CK, Gorla MS, Dreyer EB. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv Ophthalmol 1999;43(Suppl 1):142-50.
Go to original source...
Go to PubMed...
- Tsuda Y, Nakahara T, Ueda K, Mori A, Sakamoto K, Ishii K. Effect of nafamostat on N-methyl-D-aspartate-induced retinal neuronal and capillary degeneration in rats. Biol Pharm Bull 2012;35:2209-13.
Go to original source...
Go to PubMed...
- Tamaki Y, Araie M, Tomita K, Tomidokoro A, Nagahara M. Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer. Surv Ophthalmol 1997;42 Suppl 1:S52-63. doi: 10.1016/s0039-6257(97)80027-6
Go to original source...
Go to PubMed...
- Holló G. Influence of Large Intraocular Pressure Reduction on Peripapillary OCT Vessel Density in Ocular Hypertensive and Glaucoma Eyes. J Glaucoma 2017;26:e7-e10.
Go to original source...
Go to PubMed...
- Liu C, Umapathi RM, Atalay E, Schmetterer L, Husain R, Boey PY, Aung T, Nongpiur ME. The Effect of Medical Lowering of Intraocular Pressure on Peripapillary and Macular Blood Flow as Measured by Optical Coherence Tomography Angiography in Treatment-naive Eyes. J Glaucoma 2021;30(6):465-72. doi: 10.1097/IJG.0000000000001828
Go to original source...
Go to PubMed...
- Lin YH, Su WW, Huang SM, Chuang LH, Chen LC. Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated with Carteolol, Brimonidine, or Dorzolamide. J Glaucoma 2021;30:690-6.
Go to original source...
Go to PubMed...
- Zhou L, Zhan W, Wei X Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma. Front Pharmacol 2022;13:1015338. doi: 10.3389/fphar.2022.1015338
Go to original source...
Go to PubMed...
- Feher J, Pescosolido N, Tranquilli Leali FM, Cavalloti C. Microvessels of the human optic nerve head: ultrastructural and radioreceptorial changes in eyes with increased IOP. Can J Ophthalmol 2005;40:492-8.
Go to original source...
Go to PubMed...
- Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol 1990;300:5-25. doi: 10.1002/cne.903000103
Go to original source...
Go to PubMed...
- European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol 2021;105(Suppl. 1):1-169. doi: 10.1136/bjophthalmol-2021-egsguidelines
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.